$26.36
1.134.46%
At close: -
$26.36
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Kymera Therapeutics Insider Trading Activity | NASDAQ:KYMR | Benzinga
Track the latest Kymera Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Kymera Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Kymera Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 6, 2025, Ellen Chiniara, the company's CHIEF LEGAL OFFICER sold 3.13K shares for $41.75 each.
Ownership Statistics for Kymera Therapeutics Inc
Shares Outstanding
64.944M
Insider Shares Owned
1.078M
Insider Percentage Owned
1.66%
Institutional Shares Held
34.620M
Institutional Percentage Held
53.3%
| Mar 03, 2025 | Ellen Chiniara | CHIEF LEGAL OFFICER | 25.26K | $30.45 | -$68.24K | GRANT | 46.07% | 80.08K | Mar 03 | View |
| Mar 03, 2025 | Jeremy Chadwick | CHIEF OPERATING OFFICER | 23.62K | $30.45 | -$42.11K | GRANT | 53.45% | 67.80K | Mar 03 | View |
| Mar 03, 2025 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 22.96K | $30.45 | -$214.22K | GRANT | 12.84% | 201.89K | Mar 03 | View |
| Mar 03, 2025 | Jared Gollob | CHIEF MEDICAL OFFICER | 24.26K | $30.45 | -$174.79K | GRANT | 25.34% | 120.00K | Mar 03 | View |
| Jan 06, 2025 | Ellen Chiniara | CHIEF LEGAL OFFICER | -3.13K | $41.75 | -$130.64K | SELL | -5.40% | 54.83K | Jan 06 | View |
| Dec 02, 2024 | Pamela Esposito | — | 0.00 | $39.27 | -$48.63K | SELL-OPTIONS | 0.00% | 0.00 | Dec 02 | View |
| Sep 17, 2024 | Pamela Esposito | — | 0.00 | $36.07 | -$329.69K | SELL-OPTIONS | 0.00% | 0.00 | Sep 17 | View |
| Aug 26, 2024 | Jeffrey Albers | — | 0.00 | $29.72 | -$193.81K | SELL-OPTIONS | 0.00% | 0.00 | Aug 26 | View |
| Aug 22, 2024 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | — | 1.00 | $46.41 | $46.41 | BUY | 0.00% | 6.00M | Aug 20 | View |
| Jul 16, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 0.00 | $23.81 | -$1.72M | SELL-OPTIONS | 0.00% | 95.47K | Jul 15 - Jul 16 | View |
| Jul 09, 2024 | Bruce Booth | — | -453.96K | $38.21 | -$17.35M | SELL | -38.56% | 723.25K | Jul 09 | View |
| Jun 14, 2024 | Bruce Booth | — | -26.94K | $35.27 | -$950.17K | SELL | -3.25% | 802.02K | Jun 12 - Jun 13 | View |
| Jun 07, 2024 | Joanna Horobin | — | 0.00 | $17.53 | -$262.72K | SELL-OPTIONS | 0.00% | 0.00 | Jun 07 | View |
| May 23, 2024 | Jeremy Chadwick | CHIEF OPERATING OFFICER | -2.58K | $34.99 | -$90.10K | SELL | -5.51% | 44.18K | May 23 | View |
| Mar 15, 2024 | Bruce Booth | — | -127.54K | $40.25 | -$5.13M | SELL | -13.65% | 806.70K | Mar 14 - Mar 15 | View |
| Mar 13, 2024 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -353.36K | $42.20 | -$14.91M | SELL | -29.89% | 828.83K | Mar 11 - Mar 13 | View |
| Mar 13, 2024 | Bruce Booth | — | -353.36K | $42.20 | -$14.91M | SELL | -29.89% | 828.83K | Mar 11 - Mar 13 | View |
| Mar 04, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 21.03K | $41.86 | -$139.97K | GRANT | 28.15% | 95.74K | Mar 01 - Mar 04 | View |
| Mar 04, 2024 | Bruce Jacobs | CHIEF FINANCIAL OFFICER | 27.32K | $41.86 | -$164.66K | GRANT | 23.75% | 142.35K | Mar 01 - Mar 04 | View |
| Feb 29, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 0.00 | $23.54 | -$17.17K | SELL-OPTIONS | 0.00% | 74.71K | Feb 27 | View |
| Feb 21, 2024 | Jeffrey Albers | — | 0.00 | $24.70 | -$143.56K | SELL-OPTIONS | 0.00% | 0.00 | Feb 20 - Feb 21 | View |
| Feb 09, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 0.00 | $18.79 | -$1.54M | SELL-OPTIONS | 0.00% | 74.71K | Feb 09 | View |
| Jan 23, 2024 | Jeffrey Albers | — | 0.00 | $20.19 | -$197.07K | SELL-OPTIONS | 0.00% | 0.00 | Jan 23 | View |
| Jan 05, 2024 | Ellen Chiniara | CHIEF LEGAL OFFICER | -3.29K | $22.58 | -$74.42K | SELL | -8.79% | 34.20K | Jan 04 | View |
| Nov 06, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 414.11K | $12.80 | $5.30M | BUY | ∞ | 294.63K | Nov 02 - Nov 03 | View |
| Mar 03, 2023 | Elaine Caughey | CHIEF BUSINESS OFFICER | 9.84K | $31.00 | -$22.13K | GRANT | 107.66% | 18.99K | Mar 01 - Mar 02 | View |
| Mar 03, 2023 | Jared Gollob | CHIEF MEDICAL OFFICER | 17.45K | $31.00 | -$40.23K | GRANT | 30.48% | 74.71K | Mar 01 - Mar 02 | View |
| Mar 03, 2023 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 22.38K | $31.00 | -$42.47K | GRANT | 27.23% | 104.57K | Mar 01 - Mar 02 | View |
| Jan 13, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 41.01K | $30.51 | $1.25M | BUY | 1.95% | 2.15M | Jan 11 - Jan 12 | View |
| Jan 13, 2023 | Bruce Booth | DIRECTOR | -126.47K | $30.22 | -$3.82M | SELL | -12.44% | 890.15K | Jan 11 - Jan 12 | View |
| Jan 13, 2023 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -126.47K | $30.22 | -$3.82M | SELL | -12.44% | 890.15K | Jan 11 - Jan 12 | View |
| Dec 16, 2022 | Bruce Booth | DIRECTOR | -382.24K | $31.36 | -$11.99M | SELL | -29.40% | 917.81K | Dec 14 - Dec 15 | View |
| Dec 16, 2022 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -382.24K | $31.36 | -$11.99M | SELL | -29.40% | 917.81K | Dec 14 - Dec 15 | View |
| Nov 04, 2022 | Bruce Booth | DIRECTOR | -220.02K | $30.01 | -$6.60M | SELL | -18.01% | 1.00M | Nov 02 - Nov 03 | View |
| Nov 04, 2022 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -220.02K | $30.01 | -$6.60M | SELL | -18.01% | 1.00M | Nov 02 - Nov 03 | View |
| Nov 01, 2022 | Bruce Booth | DIRECTOR | -288.70K | $30.26 | -$8.74M | SELL | -21.57% | 1.05M | Oct 28 - Nov 01 | View |
| Nov 01, 2022 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -288.70K | $30.26 | -$8.74M | SELL | -21.57% | 1.05M | Oct 28 - Nov 01 | View |
| Aug 23, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 545.52K | $26.00 | $14.18M | BUY | ∞ | 257.75K | Aug 22 | View |
| May 31, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 289.43K | $14.34 | $4.15M | BUY | ∞ | 230.64K | May 26 - May 27 | View |
| May 24, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 10.10K | $14.00 | $141.39K | BUY | 4.89% | 216.77K | May 20 | View |
| May 09, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 250.00K | $19.46 | $4.87M | BUY | ∞ | 216.74K | May 05 - May 06 | View |
| Jan 31, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 130.31K | $38.96 | $5.08M | BUY | 8.84% | 1.60M | Jan 27 - Jan 31 | View |
| Jan 26, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 272.77K | $37.76 | $10.30M | BUY | 21.32% | 1.55M | Jan 24 | View |
| Jan 14, 2022 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $26.96 | -$746.48K | SELL-OPTIONS | 0.00% | 17.51K | Jan 12 | View |
| Jan 12, 2022 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $27.69 | -$2.46M | SELL-OPTIONS | 0.00% | 472.20K | Jan 10 - Jan 12 | View |
| Dec 03, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $27.82 | -$514.84K | SELL-OPTIONS | 0.00% | 17.51K | Dec 03 | View |
| Nov 02, 2021 | Jared Gollob | CHIEF MEDICAL OFFICER | -17.89K | $31.92 | -$3.51M | SELL | -42.05% | 24.66K | Nov 01 - Nov 02 | View |
| Oct 12, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $29.21 | -$2.60M | SELL-OPTIONS | 0.00% | 464.20K | Oct 08 - Oct 11 | View |
| Sep 03, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | -20.00K | $31.10 | -$621.98K | SELL | -73.38% | 7.26K | Sep 03 | View |
| Aug 27, 2021 | Richard Chesworth | CHIEF SCIENTIFIC OFFICER | 0.00 | $40.06 | -$1.36M | SELL-OPTIONS | 0.00% | 0.00 | Aug 27 | View |
| Aug 19, 2021 | Richard Chesworth | CHIEF SCIENTIFIC OFFICER | 0.00 | $35.19 | -$1.64M | SELL-OPTIONS | 0.00% | 0.00 | Aug 17 | View |
| Aug 12, 2021 | Bruce Booth | DIRECTOR | -242.13K | $61.00 | -$14.77M | SELL | -17.87% | 1.11M | Aug 11 | View |
| Aug 12, 2021 | ATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLC | 10% OWNER | -242.13K | $61.00 | -$14.77M | SELL | -4.03% | 5.76M | Aug 11 | View |
| Aug 05, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $31.07 | -$388.84K | SELL-OPTIONS | 0.00% | 452.20K | Aug 03 - Aug 04 | View |
| Aug 02, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $31.16 | -$1.77M | SELL-OPTIONS | 0.00% | 452.20K | Jul 29 - Aug 02 | View |
| Jul 28, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $31.11 | -$747.86K | SELL-OPTIONS | 0.00% | 452.20K | Jul 26 - Jul 28 | View |
| Jul 09, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $25.89 | -$2.29M | SELL-OPTIONS | 0.00% | 452.20K | Jul 08 | View |
| Jul 06, 2021 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 544.17K | $47.00 | $25.58M | BUY | ∞ | 208.54K | Jul 01 | View |
| Jun 11, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $26.73 | -$1.13M | SELL-OPTIONS | 0.00% | 412.20K | Jun 10 | View |
| Jun 09, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $26.09 | -$900.27K | SELL-OPTIONS | 0.00% | 412.20K | Jun 07 - Jun 09 | View |
| Jun 04, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $24.47 | -$447.90K | SELL-OPTIONS | 0.00% | 7.26K | Jun 03 | View |
| May 14, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $26.07 | -$395.53K | SELL-OPTIONS | 0.00% | 397.20K | May 12 | View |
| Apr 26, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $21.16 | -$549.65K | SELL-OPTIONS | 0.00% | 397.20K | Apr 22 - Apr 26 | View |
| Apr 19, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 6.00K | $21.17 | -$201.05K | SELL-OPTIONS | 1.53% | 397.20K | Apr 15 - Apr 19 | View |
| Apr 12, 2021 | Nello Mainolfi | CHIEF EXECUTIVE OFFICER | 0.00 | $17.85 | -$1.51M | SELL-OPTIONS | 0.00% | 376.20K | Apr 08 - Apr 12 | View |
| Mar 16, 2021 | Bruce Booth | DIRECTOR | -229.35K | $56.50 | -$12.96M | SELL | -17.09% | 1.11M | Mar 12 | View |
| Mar 16, 2021 | ATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLC | 10% OWNER | -229.35K | $56.50 | -$12.96M | SELL | -3.22% | 6.89M | Mar 12 | View |
| Mar 15, 2021 | Jared Gollob | CHIEF MEDICAL OFFICER | -5.00K | $30.72 | -$888.89K | SELL | -10.52% | 42.55K | Mar 11 - Mar 15 | View |
| Mar 15, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $31.12 | -$580.73K | SELL-OPTIONS | 0.00% | 0.00 | Mar 11 - Mar 15 | View |
| Mar 08, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $26.36 | -$485.67K | SELL-OPTIONS | 0.00% | 0.00 | Mar 08 | View |
| Mar 05, 2021 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 0.00 | $23.43 | -$854.03K | SELL-OPTIONS | 0.00% | 0.00 | Mar 03 | View |
| Feb 24, 2021 | Jared Gollob | CHIEF MEDICAL OFFICER | -37.06K | $50.68 | -$1.88M | SELL | -43.81% | 47.55K | Feb 22 - Feb 24 | View |
| Feb 19, 2021 | Jared Gollob | CHIEF MEDICAL OFFICER | -22.94K | $56.42 | -$1.29M | SELL | -21.33% | 84.61K | Feb 17 - Feb 19 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.